Product Information

ORQUIDEA 0.35 MG TABLET is a generic product labeled by Xiromed LLC, priced at $0.1026 per EA under NDC 70700031685. Its NADAC has been published 67 times since Aug 13, 2025.

FDA first approved this application on Jun 24, 2013. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ORQUIDEA 0.35 MG TABLET

norethindrone
$0.1026per EA

Strength

.35 mg/1

Manufacturer

Xiromed LLC

NDC

70700031685

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

NORETHINDRONE

Approval Type

Generic (ANDA)

FDA Application

ANDA201483

FDA Approved

6/24/2013

TE Code

AB1

On Market Since

1/29/2025

Pharmacological Classes

Progesterone Congeners
Progestin

Price Statistics

The NADAC for ORQUIDEA 0.35 MG TABLET has been published 67 times since Aug 13, 2025, and over the history we have for it it has risen 16.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1026 per EA
All-time high$0.1026 (Nov 18, 2026)
All-time low$0.0849 (Dec 17, 2025)
52-week high$0.1026
52-week low$0.0849
Median price$0.0922
Average price$0.0917
Largest weekly change+6.2% (Oct 21, 2026)
Weeks tracked67
Tracking sinceAug 13, 2025

Price History

1W

+4.5%

1M

+11.0%

3M

+13.2%

6M

+8.8%

1Y

+17.7%

3Y

N/A

5Y

N/A

All

+16.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ORQUIDEA 0.35 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ORQUIDEA 0.35 MG TABLET, manufactured by Xiromed LLC, is $0.1026 per EA (NDC 70700031685), effective Nov 18, 2026.

How has the price of ORQUIDEA 0.35 MG TABLET changed over time?

Over the history we have for it, the NADAC for ORQUIDEA 0.35 MG TABLET has risen 16.3%. It has been tracked across 67 weekly CMS publications since Aug 13, 2025.

What are the highest and lowest recorded NADAC prices for ORQUIDEA 0.35 MG TABLET?

Since Aug 13, 2025, the NADAC for ORQUIDEA 0.35 MG TABLET has ranged from a low of $0.0849 (Dec 17, 2025) to a high of $0.1026 (Nov 18, 2026), with a median of $0.0922 per EA.

Are there cheaper alternatives to ORQUIDEA 0.35 MG TABLET?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NORETHINDRONE 0.35 MG TABLET, is $0.0906 per EA — about 12% below ORQUIDEA 0.35 MG TABLET.

Who manufactures ORQUIDEA 0.35 MG TABLET?

ORQUIDEA 0.35 MG TABLET (NDC 70700031685) is labeled by Xiromed LLC, and CMS classifies it as a generic product.